Clarivate/$CLVT
13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX
About Clarivate
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.
Ticker
$CLVT
Sector
Primary listing
NYSE
Industry
Professional Services
Headquarters
Employees
12,000
ISIN
JE00BJJN4441
Website
Clarivate Metrics
BasicAdvanced
$2.9B
-
-$0.97
1.50
-
Price and volume
Market cap
$2.9B
Beta
1.5
52-week high
$7.11
52-week low
$3.04
Average daily volume
5M
Financial strength
Current ratio
0.879
Quick ratio
0.769
Long term debt to equity
90.993
Total debt to equity
91.411
Interest coverage (TTM)
0.83%
Profitability
EBITDA (TTM)
963.2
Gross margin (TTM)
66.06%
Net profit margin (TTM)
-26.32%
Operating margin (TTM)
9.91%
Effective tax rate (TTM)
-14.98%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
1.20%
Return on equity (TTM)
-12.20%
Valuation
Price to revenue (TTM)
1.172
Price to book
0.58
Price to tangible book (TTM)
-0.59
Price to free cash flow (TTM)
8.793
Free cash flow yield (TTM)
11.37%
Free cash flow per share (TTM)
48.22%
Growth
Revenue change (TTM)
-3.50%
Earnings per share change (TTM)
-41.39%
3-year revenue growth (CAGR)
6.21%
3-year earnings per share growth (CAGR)
24.11%
What the Analysts think about Clarivate
Analyst ratings (Buy, Hold, Sell) for Clarivate stock.
Bulls say / Bears say
Clarivate's strategic shift to a subscription-based model aims to achieve 87% recurring revenue by 2025, enhancing revenue predictability and stability. (seekingalpha.com)
The company's Q1 2025 earnings reported revenue of $593.7 million, surpassing analyst expectations by 3.56%, indicating strong operational performance. (finviz.com)
Clarivate's recent acquisitions, including MotionHall and Global QMS, expand its offerings in the life sciences and healthcare sectors, potentially driving future growth. (wikipedia.org)
Barclays reduced its price target for Clarivate to $4.00, reflecting concerns about the company's financial outlook. (marketbeat.com)
Clarivate's Q4 2024 revenue declined by 3.0% year-over-year, with organic revenues decreasing by 0.7%, indicating challenges in achieving growth. (stocktitan.net)
Analysts have expressed concerns about Clarivate's high leverage and insufficient cash flows, which may necessitate refinancing and could impact financial stability. (seekingalpha.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.
Clarivate Financial Performance
Revenues and expenses
Clarivate Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Clarivate stock?
Clarivate (CLVT) has a market cap of $2.9B as of June 20, 2025.
What is the P/E ratio for Clarivate stock?
The price to earnings (P/E) ratio for Clarivate (CLVT) stock is 0 as of June 20, 2025.
Does Clarivate stock pay dividends?
No, Clarivate (CLVT) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Clarivate dividend payment date?
Clarivate (CLVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Clarivate?
Clarivate (CLVT) has a beta rating of 1.5. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
